Form 8-K - Current report:
SEC Accession No. 0001437749-18-005833
Filing Date
2018-03-29
Accepted
2018-03-29 16:18:40
Documents
15
Period of Report
2018-03-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K kmph20180326_8k.htm 8-K 25173
2 EXHIBIT 99.1 ex_109019.htm EX-99.1 174897
3 EXHIBIT 99.2 ex_109020.htm EX-99.2 6212
4 slide10.jpg GRAPHIC 92852
5 slide09.jpg GRAPHIC 181039
6 slide08.jpg GRAPHIC 186907
7 slide07.jpg GRAPHIC 326748
8 slide06.jpg GRAPHIC 243029
9 slide05.jpg GRAPHIC 347294
10 slide04.jpg GRAPHIC 361176
11 slide03.jpg GRAPHIC 111367
12 slide02.jpg GRAPHIC 461263
13 slide01.jpg GRAPHIC 92852
14 ex99-1img002.jpg GRAPHIC 3740
15 ex99-1img001.jpg GRAPHIC 2054
  Complete submission text file 0001437749-18-005833.txt   3518528
Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 18723188
SIC: 2834 Pharmaceutical Preparations